Gapping down
In reaction to earnings/guidance:
- BLUE -20.1%, EPZM -13.4% (announces Chief Executive Officer succession plan ) ELAN -8%, AVYA -7.7%, DRNA -1.4%, GOLD -1.3%,
Other news:
- AXSM -45.5% (announces AXS-05 achieves primary and key secondary endpoints in the MERIT Phase 2 Trial in treatment resistant depression)
- BIVI -34.2% (priced of its underwritten public offering of 2,500,000 shares of its Class A common stock at a public offering price of $8.00/share)
- ETON -13.8% (today is PDUFA date for NDA for topiramate oral solution)
- VNOM -4.9% (announces Midland Basin acquisition)
- DMRC -4.6% (files for 3,740,240 share common stock offering by selling shareholders)
- VNE -3.6% (to engage in discussions with Qualcomm (QCOM))
- ZI -3.2% (announces secondary offering of 20 mln shares of Class A common stock by holders )
- OXY -3% (Carl Icahn lowers active stake following the sale of nearly 3.5 mln shares)
- AQB -3% (files for 18,219,824 share common stock offering by selling shareholders)
- LXRX -2.2% (files for $200 mln mixed securities shelf offering)
- GOLD -1.3% (announces second $250 million ($0.14 per share) return of capital tranche in addition to a $0.09 per share quarterly dividend)
- PLL -1.3% (provides an update as to the county rezoning process for its Carolina Lithium Project)
- REAL -0.9% (provides monthly business update for July), .
Analyst comments:
- MRTN -2.5% (downgraded to Sector Weight from Overweight at KeyBanc)
- GLP -2% (downgraded to Underweight from Equal Weight at Barclays; tgt $21)
- WYNN -1.9% (downgraded to Neutral from Buy at BofA )
- DLTR -1.7% (downgraded to Hold from Buy at Deutsche Bank)
- WERN -1.1% (downgraded to Sector Weight from Overweight at KeyBanc)
- ONEM -1% (downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $31)
- DRI -0.9% (downgraded to In-line from Outperform at Evercore ISI), .